|
Centre for Policy on Ageing | |
 | |
|
Barriers and facilitators for guideliines with depression and anxiety in Parkinson's disease or dementia | Author(s) | Zahra Goodarzi, Heather M Hanson, Nathalie Jette |
Journal title | Canadian Journal on Aging, vol 37, no 2, June 2018 |
Publisher | Cambridge University Press, June 2018 |
Pages | pp 185-199 |
Source | http://www.cambridge.org/cjg |
Keywords | Parkinson's disease ; Dementia ; Depression ; Anxiety ; Medical care ; Diagnosis ; Therapeutics ; Canada. |
Annotation | A primary objective of this study was to understand the barriers and facilitators associated with the implementation of high-quality clinical practice guidelines (CPGs) for depression and anxiety in patients with dementia or Parkinson's disease (PD). The authors conducted focus groups or interviews with participants experiencing dementia or PD, their caregivers and physicians in Calgary, Alberta, and applied the theoretical domains framework and behaviour change wheel to guide data collection and perform a framework analysis. 33 physicians and seven PD patients and/or caregivers participated. The study reported barriers and facilitators to the implementation of guideline recommendations for diagnosis, management, and the use of the guidelines. An overarching theme was the lack of evidence for depression or anxiety disorders in dementia or PD, which was prominent for anxiety versus depression. Patients noted difficulties with communicating symptoms and accessing services. Although guidelines are available, physicians have difficulty implementing certain recommendations due primarily to a lack of evidence regarding efficacy. (JL). |
Accession Number | CPA-180525244 A |
Classmark | CR6: EA: ENR: ENP: LK: LK7: LL: 7S |
Data © Centre for Policy on Ageing |
|
...from the Ageinfo database published by Centre for Policy on Ageing. |
| |
|